Increased Risk Of Death From Drug Used In Coronary Artery Bypass Graft Surgery

... Aprotinin, a drug used for limiting blood loss in patients undergoing cardiac surgery, is associated with an increased risk of death during five years following the surgery, according to a new study in the February 7 issue of JAMA.Aprotinin was first approved for use in high-risk patients needing coronary artery surgery in the United States in 1993. [click link for full article] ...